20 employees
Biotts develop proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology, and autoimmune diseases.
2018
$1.5M
from 2 investors over 2 rounds
Biotts raised undisclosed on October 5, 2021
Investors: Google Developers Launchpad Program
Biotts raised $1.5M on May 22, 2020
Investors: Montis Capital